Skip to Content
Browse all medications
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Advanced
Phonetic
Search:
Drugs A-Z
Complete A - Z Drug Index
Drugs by Condition
Drugs by Class
Drug Side Effects
Drug Dosage
Pregnancy Warnings
Breastfeeding Information
International Drugs
Generic Drugs
Veterinary Drugs
Natural Products
Phonetic Search
Harvard Health Topics
Medical Encyclopedia
Pill Identifier
Interactions Checker
News / Alerts
FDA Medwatch Drug Alerts
FDA Labeling Changes
Daily MedNews for Consumers
Pharmaceutical Industry News
Clinical Trial News
New Drug Approvals
New Drug Applications (Pipeline)
Get News via RSS
Get News via Twitter
Drugs.com Blog
Health Professionals
Professional Resource Center
FDA Prescribing Information
AHFS DI Monographs
A-Z Drug Facts for the Professional
Drug Interactions Checker
Patient CareNotes for the Professional
Natural Products Database
Medical Conferences
Pharmaceutical Company Directory
Medical Dictionary
Phonetic Drug Search
Community
Ask Medical Questions
Join Support Groups
Forum - Discussion Boards
Mednotes
Apps
Home
›
News
›
Pharma Industry News
› Archive
Pharmaceutical Industry News Archive
Get news
By email
or subscribe to our
News feeds
.
All News
Consumer
Pharma
New Drugs
Pipeline
Clinical Trials
January 2008
January 2
PRWT Acquires Chemical Manufacturing Facility from Merck & Co., Inc.
Biovail Announces Supply Agreement for Commercialization of Extended-Release Tramadol
Use of Opioids to Treat Pain in Emergency Departments on the Rise, but Racial Differences in Opioid Use Still Exist
IDM Pharma Announces Termination of Uvidem Development Collaboration and Expected Restructuring in Connection With Evaluation of Strategic Alternatives
Pfizer Inc Announces Completion of the Tender Offer Relating to Outstanding Shares of Coley Pharmaceutical Group, Inc.
Beijing Med-Pharm Receives Business License for Alliance BMP Limited
Covalence Ethical Ranking 2007
January 3
Celgene/Pharmion Hart-Scott-Rodino (HSR) Thirty Day Waiting Period Expires
Addex and Merck & Co., Inc. Enter License Agreement to Develop a Drug Candidate for Schizophrenia
B-cell Chronic Lymphocytic Leukemia (B-CLL): Expanded Labeling for MabCampath in Europe
Crucell Enters Agreement with Sanofi Pasteur for Next-generation Biologicals Against Rabies
Phase Bioscience Announces New Collaboration with Centocor Research and Development
Galapagos Enters Into Oncology Target Discovery Collaboration with Janssen Pharmaceutica
Bruker AXS Announces Agreement to Acquire Elemental Analysis Company JUWE Laborgeraete GmbH
Novacea Provides Corporate and Development Update
Pfizer to Appeal Canadian Federal Court Ruling on Lipitor Patent; Court's Decision Will Have No Immediate Commercial Impact
FDA Issues Communication Communication about an Ongoing Safety Review of ESAs
January 4
2007 - The Year in Drugs
Illumina Announces Corporate Reorganization
BioMarin and Genzyme Restructure Aldurazyme 50/50 Joint Venture
WuXi PharmaTech to Acquire AppTec Laboratory Services, Inc.
IMS Health Announces Restructuring Actions to Improve Operating Efficiencies, Address Client Priorities
Berkery Noyes Represented The Thomson Corporation in the Sale of CenterWatch and New England Institutional Review Board to Jobson Medical Information
January 7
Magen BioSciences Licenses Dermatology Assets from Lilly
Contract Research Organization Market - What Pharmaceutical and Biotechnology Companies Want
Pfizer and Taisho Finalize Agreement for Novel Schizophrenia Drug Candidate
VaxGen Provides Update on Raven Transaction Progress
Boston Scientific Completes Sale of Auditory Business and Drug Pump Development Program
Access Pharmaceuticals Closes Acquisition of Somanta Pharmaceuticals
Encorium Group, Inc. Announces the Signing of a $2.0 Million Contract for Data Management Services for a Global Pharmaceutical Company
ATMI Acquires LevTech
Faust Pharmaceuticals Announces Research Agreement with Takeda
Inclinix Secures $10 Million in Expansion Funding
Omnicom's BBDO Invests in China's Shunya Communications Group
NextGen Sciences Announces Commercial Alliance with Paragon Bioservices, Inc
Boston Scientific Completes Sale of Cardiac Surgery and Vascular Surgery Businesses
Tacere Therapeutics Enters Collaboration and License Agreement With Pfizer To Develop and Commercialize RNAi Hepatitis C Drug
The GVK BIO Clinical Pharmacology Unit Granted Major Accreditations
Synovate Healthcare Boosts Global Oncology Portfolio Through Acquisition of Oncology Inc.
FDA MedWatch - Bisphosphonates- Possible Cause of Severe and Sometimes Incapacitating Bone, Joint, and/or Muscle Pain
MedImmune Broadens Focus of Venture Capital Fund to Include New Therapeutic Areas
Cambrex Signs Agreement To Acquire ProSyntest AS
Court of Appeals Upholds Verdicts in Favor of Cordis Corporation on Patents Infringed by Medtronic, Inc. and Boston Scientific Corporation
January 8
NicOx Signs Extension of Ophthalmology Agreement With Pfizer
Cetero Research Adds DGD Research, Enhancing Their Therapeutic Capabilities and Expertise to Include Endocrinology and Metabolic Disorders
Reckitt Benckiser Receives Hart-Scott-Rodino Antitrust Clearance for Acquisition of Adams Respiratory Therapeutics
Cetero Research Adds DGD Research, Enhancing Their Therapeutic Capabilities and Expertise to Include Endocrinology and Metabolic Disorders
Anthera Pharmaceuticals Acquires the Worldwide Rights to a BAFF Inhibitor for the Treatment of Lupus and Other Autoimmune Diseases
Boston Scientific Announces Court Decision
Seattle Genetics Earns Milestone Payment from Initiation of SGN-40 Phase Ib Clinical Trial in Combination with Rituxan for Non-Hodgkin Lymphoma
Genzyme and Isis Announce Strategic Alliance Including Exclusive Worldwide License of Mipomersen
Introducing Latest Study on 'Optimizing Partnerships with Contract Organizations: Effective Management, Key Issues and the Development of Virtual Pharmacos'
ViroPharma Provides Update on Vancocin
Committee on Energy and Commerce Opens Investigation into Celebrity Drug Endorsements
FDA Warnings Affected Prescriptions of Antidepressants to Youth
Removing Thimerosal from Vaccines Did Not Reduce Autism Cases in California
PII Acquires Pharmaterials Ltd
Iris Pharma and Clirophtha Merger Creates Unique Ophthalmology CRO
Iris Pharma and Clirophtha Merger Creates Unique Ophthalmology CRO
Biogen Idec and PDL BioPharma License the Rights to Develop Volociximab in Ophthalmic Indications to Ophthotech
ResearchPoint Global Announces Addition of M2S to Network
Acquisition of Lymphatix Brings VEGF Gene Rights and Technology to Catalyse Ark's Gene-Based Medicine Programmes
Praxis' Patient Recruitment Campaign Saves 300 Days off Enrollment for Women's Health Study
Genzyme Reports 21 Percent Increase in Fourth-Quarter Revenue
Amgen Updates 2007 Adjusted EPS Guidance and Outlines 2008 Expense Outlook at the JP Morgan Healthcare Conference
First Consulting Group Prevails at Court Hearing
January 9
Avista Capital Partners Completes Acquisition of Bristol-Myers Squibb Medical Imaging
D.C. Council Passes Safe Rx Act
Morphotek Announces Agreement for the Development of Antibodies to Treat Prostate Cancer
Barr Confirms Patent Challenge of Eloxatin Injectable, 5mg/mL
PPRS Renegotiation: Joint ABPI/DH Statement
Quintiles Central Lab, Clinical Development in China to Expand, Relocate to New Facility
January 10
Pfizer Wins Key New York State Court Ruling on Celebrex
Omeros Corporation Files Registration Statement for Proposed Initial Public Offering
Invitrogen Announces Acquisition of CellzDirect
Encorium Group, Inc. Announces Signing of $1.7 Million in Contracts with Leading International Biotechnology Company for Clinical Trials in Oncology and Rheumatology
Jerini Announces Collaboration Agreement with Baxter to Develop Novel Peptide for Use in Therapeutic Protein Purification
Noven Receives FDA Warning Letter Related to Mid-2007 Facility Inspection
January 11
Forest Laboratories, Inc. and Merz Pharma GmbH & Co. KgaA File Lawsuits Against Several Companies for Patent Infringement
RxElite Announces Acquisition of Assets of FineTech Laboratories
CSS Informatics Signs Solutions Partner Agreement with Nimbus Partners
Atlantis Holding Corp. Announces Merger With Medical Institutional Services, Inc.
January 14
Compugen Announces GPCR Ligand Discovery and License Option Agreement With Merck
Inspire Announces Its Termination of Bilastine Licensing Agreement
Pfizer Receives Initial Communication from U.S. Patent and Trademark Office Regarding Lipitor Basic Patent
Thimerosal-Autism Link Rejected by Maryland Court
Galapagos Extends Drug Discovery Collaboration with Lilly in Nuclear Hormone Receptor Research
Bridge Laboratories Receives $18 Million Financial Backing
BLM, the Leading Independent Agency, to Combine with Arena Media Communications
A.P. Pharma Announces Executive Officer Departure
Supreme Court Declines to Consider Whether Those Near Death Have Right of Access to Experimental Drugs
January 15
Genentech Announces Full Year and Fourth Quarter 2007 Results
Forest Laboratories, Inc. Reports Q3'08 Diluted Earnings Per Share of $0.96. Raises FY2008 EPS Guidance Range to $3.35-$3.45 Excluding $0.15 per Share Licensing Charge
Novo Nordisk Refocuses Its Activities Within Inhaled Insulin and Discontinues the Development of AERx
Reps. Dingell, Stupak to Continue ENHANCE Trial Investigation
First Head to Head Study Comparing Crestor and Lipitor Effects on the Treatment of Atherosclerosis
Akrimax Pharmaceuticals Purchases Rouses Point Plant
January 16
ACC Statement on Enhance Trial
EU Antitrust: Commission Launches Sector Inquiry Into Pharmaceuticals with Unannounced Inspections
NitroMed Reports on BiDil XR Progress Following FDA Meeting, Announces Restructuring and Suspension of BiDil Sales Force, and Retains Investment Bank to Advise on Strategic Options
ImpactRx Broadens Innovative Research Capability Through Acquisition of Paragon Research and Consulting
Sandoz Fully Cooperating with European Commission Investigation of the Pharmaceuticals Industry
HIV/AIDS Update - Reyataz (atazanavir) Package Insert Revisions
Canon Communications to Launch New Event for Drug and Medical Device Marketing
FDA Issues a Public Health Advisory on Edetate Disodium (Marketed as Endrate and Generic Products)
January 17
QLT Announces Visudyne Sales for Fourth Quarter and Fiscal Year 2007
QLT Inc. Announces Initial Steps in Strategic Restructuring
Ventana Responds to Extension of Roche's Unsolicited Tender Offer
Novartis Achieves Record Results in 2007 Underscoring Benefits of Strategic Healthcare Portfolio
Reps. Dingell, Stupak Raise Concerns, Questions on ENHANCE Trial
AAJ Demands FDA Withdraw Rule Allowing Drug Companies to Claim Immunity for Failing to Warn Patients of Potential Drug Hazards
FDA MedWatch - Edetate Disodium (marketed as Endrate and generic products) - Important Safety Considerations For Healthcare Professionals
Eisai and MGI Pharma Announce Early Termination of HSR Waiting Period for Eisai's Acquisition of MGI Pharma
Genedata Provides Expressionist Platform to Eisai Research Institute
Malvern Instruments Acquires Viscotek Corporation
January 18
Jan Marini Skin Research Suspends Sales of Popular Eyelash Products
StemCells, Inc. Provides Batten's Clinical Trial Update
Actavis Acquires Italian Manufacturing Site from Pfizer
Roche Invests 430 Million Swiss Francs at Sites in Germany and Switzerland Centres for the Research, Development, Production and Filling of Innovative Biopharmaceuticals to be Expanded
U.S. Appeals Court Upholds Finding that Abbott Infringed Innogenetics’ HCV Genotyping Patent, and Orders Abbott to Pay Innogenetics Monetary Damages and Sanctions
Pfizer Statement on Chantix (varenicline) Labeling Update in the United States
GTC Biotherapeutics Receives Notice Related to Nasdaq Minimum Closing Bid Price Rule
Schering-Plough CEO to Buy $2 Million in Common Shares
New Jersey Attorney General Announces Subpoena of Pharmaceutical Firm Over Marketing of Injectable Drug Enbrel
January 22
CytRx Provides Update on Phase IIb Arimoclomol Clinical Trial for ALS
Ortho Evra Prescribing Information Updated
Roche to Acquire Ventana for $89.50 per share
GSK Does Not Option XL784 for Further Development
Wyeth and Teva Pharmaceuticals Extend the Standstill Period Relating to Teva's Launch of Generic Pantoprazole
19 Percent of Office-Based Physicians Refuse to See Pharmaceutical, Biotech and Medical Device Sales Reps
Exelixis and Bristol-Myers Squibb to Co-Develop XL139, an Inhibitor of the Hedgehog Pathway
Aureon Laboratories to Collaborate with Pfizer, Inc. to Establish Quantitative Biometrics for Assessing Therapeutic Response of Prostate Cancer Patients Treated with Hormone Therapy
Teva to Acquire CoGenesys
Elsevier Acquires Edra S.p.A
January 23
Abbott Reports 16.1 Percent Sales Growth in Fourth Quarter
Reps. Dingell, Stupak Continue Enhance Trial Inquiry
Oversight and Government Reform Committee Chairman Waxman Requests FDA Provide Documents Regarding Drug Company Marketing Loophole
Paul Capital Healthcare Purchases Additional Royalty Interest in GlaxoSmithKline's Rotarix
Eisai Announces Satisfaction of Conditions to Tender Offer for MGI Pharma Shares
Pfizer Reports Fourth-Quarter and Full-Year 2007 Results and 2008 Financial Guidance
Bayer Establishes US Special Access Program for Leukine While Replacing Current Liquid Formulation
Dalton Medicinal Chemistry Partners Achieves Another Milestone in Collaboration with Boehringer Ingelheim (Canada) Ltd.
U.S. Federal Trade Commission Clears Global Licensing and Development Agreement Between BioMS Medical and Lilly
Direvo to Collaborate with Medimmune on Therapeutic Protease for the Treatment of CNS Diseases
U.S. Patent Office Rejects Key HIV/AIDS Drug Patents at PUBPAT Request: Government Finds Prior Art Submitted By PUBPAT Invalidates All of Gilead Sciences' Claims
January 24
Baxter Achieves Record Sales and Earnings for Full-Year 2007
GlaxoSmithKline and TB Alliance Renew Tuberculosis Drug Discovery Program
Stanford Study Finds Transplant Patient Thrives 2 Years After Stopping Immunosuppressive Drugs
January 25
Amgen's Fourth Quarter 2007 Adjusted Earnings Per Share (EPS) Increased 11 Percent to $1.00; Full Year 2007 Adjusted EPS Increased 10 Percent to $4.29
TransTech Pharma, Inc. Acquires Three Programs for the Treatment of Metabolic Disorders from Novo Nordisk
Allergan, Inc. Comments on Botox (Botulinum Toxin Type A) Safety Profile
ApoCell to Conduct Studies in Support of Novel Pfizer Cancer Drug Trial
LabCorp Announces Definitive Agreement to Acquire Tandem Labs, Inc.
EMEA Statement on the Safety of Gardasil
Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Second Generation Niacin Receptor Agonist Under Its Collaboration With Merck & Co., Inc.
EMEA Recommends New Warnings and Contraindications for Rosiglitazone
Sen. Grassley Asks Questions About Controversy Over Delayed Release of Drug Study Involving Vytorin
MicroIslet Announces Management Change and Receives Working Capital Loan
FDA Issues Early Communication about an Ongoing Review of Vytorin
January 28
Over-the-counter eardrops may cause hearing loss or damage
Allergan, Inc. Responds to Public Citizen's Allegation Regarding a Fatality Following Botox Cosmetic Treatment
Merck Receives Not Approvable Letter from FDA for OTC Mevacor (lovastatin) 20 mg
German Federal Cartel Office Clears Celgene to Acquire Pharmion
Abbott and Eisai Announce Changes in the Sales Scheme in Japan for Adalimumab, A Fully Human Monoclonal Anti-TNF- Antibody
Gastrotech Signs Licensing Agreement with Eli Lilly Following Positive Clinical Data on Compound for Irritable Bowel Syndrome
Canon Communications Announces Details of Drug Development Summit
Bausch & Lomb and CrystalGenomics Announce R&D Collaboration
January 29
Lilly Caps Successful Year with Strong Fourth-Quarter Results
Eisai Completes Acquisition of MGI Pharma
Theratechnologies Announces Review of Strategic Alternatives and Filing of Preliminary Base Shelf Prospectus for Up to $35 Million Equity Financing
PAION Agreement with Lundbeck Comes Into Force, Securing Future Desmoteplase Development and EUR 8 Million Upfront-payment to PAION
U.S. Pharmacopeia 8th Annual MEDMARX Report Indicates Look-Alike/Sound-Alike Drugs Lead to Thousands of Medication Errors Nationwide
January 30
FDA Sends Warning Letter to Novartis Vaccines and Diagnostics
Teva Announces Wyeth Voids Standstill Agreement on Generic Protonix
Merck Announces 2007 Financial Results Reflecting Revenue Growth from Key Products
Wyeth Announces Launch of Own Generic Version of Protonix
Neose Announces Discontinuation of NE-180 Program
Kyowa Hakko Nine-month Operating Income up 20.6%; Raises Full-year Forecasts
Record Operating Results for Roche Again in 2007
Taisho Revises Earnings Forecasts for FY2007 Full Year
Prasco to Distribute Wyeth's Own Generic Versions of Protonix Delayed-Release Tablets
Allergan Reports Fourth Quarter Operating Results
Common Drug-Releasing Coronary Stents Appear to Have Similar Clinical Outcomes
Solvay Pharmaceuticals, Inc. Announces Retirement of CEO Laurence Downey and Appointment of Stephen Hill as New President and Chief Executive Officer
January 31
Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year
P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company
ImClone Systems Reports Fourth Quarter and Full Year 2007 Financial Results
Bristol-Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007
PsychoGenics Expands Drug Discovery Relationship with Eli Lilly and Company
Cell Therapeutics, Inc. (CTI) Cuts Net Operating Expenses 35% and Expands Commercial Team to Support Zevalin Sales and Applications Seeking Two Product Approvals in 2009
AstraZeneca PLC, Fourth Quarter and Full Year Results 2007
Novo Nordisk: Financial statement for 2007
Innate Pharma and Novo Nordisk A/S Partnership Refocused on the Inflammatory Field
FDA MedWatch- Antiepileptic Drugs- FDA Analysis Showed Patients Receiving Antiepileptic Drugs Had Approximately Twice The Risk of Suicidal Behavior Or Ideation
Pharmaceutical Industry News Archive
2012
January
,
February
2011
January
,
February
,
March
,
April
,
May
,
June
,
July
,
August
,
September
,
October
,
November
,
December
2010
January
,
February
,
March
,
April
,
May
,
June
,
July
,
August
,
September
,
October
,
November
,
December
2009
January
,
February
,
March
,
April
,
May
,
June
,
July
,
August
,
September
,
October
,
November
,
December
2008
January
,
February
,
March
,
April
,
May
,
June
,
July
,
August
,
September
,
October
,
November
,
December
2007
January
,
February
,
March
,
April
,
May
,
June
,
July
,
August
,
September
,
October
,
November
,
December
2006
January
,
February
,
March
,
April
,
May
,
June
,
July
,
August
,
September
,
October
,
November
,
December
2005
January
,
February
,
March
,
April
,
May
,
June
,
July
,
August
,
September
,
October
,
November
,
December
2004
January
,
February
,
March
,
April
,
May
,
July
,
August
,
September
,
October
,
November
,
December
2003
January
,
February
,
March
,
April
,
May
,
June
,
July
,
August
,
September
,
October
,
November
,
December
2002
January
,
April
,
May
,
June
,
August
,
September
,
October
,
November
,
December
More News Resources
FDA Medwatch Drug Alerts
FDA Drug Safety Labeling Changes
Daily MedNews
Pharma Industry News
New Drug Approvals
New Drug Applications
Clinical Trial Results
Generic Drug Approvals
Monthly Update Archive
Printable Version
Email
Recommend
Tweet
Save or Share
Search:
Sign In
or
Register
Username
Password
Forgot password?
FDA Consumer Updates
Primatene Mist With Chlorofluorocarbons No Longer Available After Dec. 31, 2011
HCG Diet Products are Illegal
Lock it Up: Medicine Safety in Your Home
Reducing Fever in Children: Safe Use of Acetaminophen
More FDA Updates...
Recently Approved
Mitosol
Mitosol (mitomycin) is an antimetabolite indicated as an adjunct to ab externo glaucoma surgery.
Sklice
Sklice (ivermectin) Lotion is a pediculicide indicated for the topical treatment of head lice infestations in ...
Jentadueto
Jentadueto (linagliptin and metformin) is a dipeptidyl peptidase-4 (DPP-4) inhibitor and biguanide ...
Kalydeco
Kalydeco (ivacaftor) is a cystic fibrosis transmembrane conductance regulator (CFTR) potentiator indicated ...
Erivedge
Erivedge (vismodegib) is a hedgehog pathway inhibitor for the treatment of patients with advanced basal cell ...
More...
Get Updates by Email
Email me:
FDA Medwatch Alerts
News Roundup
Daily
Weekly
Monthly
Email
(web6)